title: Neuropsychiatric symptoms during treatment with interleukin-2.
authors.forename: J
authors.initials: J
authors.lastname: Buter
authors.forename: E G
authors.initials: EG
authors.lastname: de Vries
authors.forename: D T
authors.initials: DT
authors.lastname: Sleijfer
authors.forename: P H
authors.initials: PH
authors.lastname: Willemse
authors.forename: N H
authors.initials: NH
authors.lastname: Mulder
mesh_terms: D000328:Adult; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary; D002493:Central Nervous System Diseases / Q000139:chemically induced*; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D019966:Substance-Related Disorders / Q000209:etiology*
chemical_list: D007376:Interleukin-2